123 - COVID19 and Enrollment of Critically Ill Children in a Clinical Trial

Sarah B.. Kandil, Yale School of Medicine, New Haven, CT, United States; David J. Panisello-Manterola, Yale-New Haven Children's Hospital, Elmira, NY, United States; Madhuradhar Chegondi, University of Illinois College of Medicine, Peoria, IL, United States; Christine Allen, Oklahoma Childrens Hospital at OU Health, Oklahoma City, OK, United States; Jill M. Cholette, Golisano Children's Hospital at The University of Rochester Medical Center, Rochester, NY, United States; Michele Kong, University of Alabama School of Medicine, Birmingham, AL, United States; Matthew Pinto, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY, United States; E Vincent Faustino, Yale School of Medicine, New Haven, CT, United States; Christie L. Glau, Perelman School of Medicine at the University of Pennsylvania, Newtown Square, PA, United States; Hilary Schreiber, Children's Hospital of Wisconsin, Milwaukee, WI, United States